Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 7642: Activated FAP+ cancer-associated fibroblasts in non-muscle invasive bladder cancer are associated with progression to muscle-invasive disease

Cancer Res (2024) 84 (6_Supplement): 7642.

https://doi.org/10.1158/1538-7445.AM2024-7642

Published: 22 March 2024

View articletitled, Abstract 7642: Activated FAP+ cancer-associated fibroblasts in non-muscle invasive bladder cancer are associated with progression to muscle-invasive disease

Journal Articles

Abstract 4627: Metastatic renal cell carcinoma with occult primary: Clinical and biological evidence for a new entity of cancers of unknown primary that beneficiates from tissue-tailored treatment

Cancer Res (2024) 84 (6_Supplement): 4627.

https://doi.org/10.1158/1538-7445.AM2024-4627

Published: 22 March 2024

View articletitled, Abstract 4627: Metastatic renal cell carcinoma with occult primary: Clinical and biological evidence for a new entity of cancers of unknown primary that beneficiates from tissue-tailored treatment

Journal Articles

Abstract 4637: National multidisciplinary tumor board improves diagnostic stratification and therapeutic management in cancers of unknown primary

Cancer Res (2024) 84 (6_Supplement): 4637.

https://doi.org/10.1158/1538-7445.AM2024-4637

Published: 22 March 2024

View articletitled, Abstract 4637: National multidisciplinary tumor board improves diagnostic stratification and therapeutic management in cancers of unknown primary

Journal Articles

Abstract 5224: Genome-wide interaction study of smoking and bladder cancer risk: results from the COBLAnCE cohort

Maryam Karimi, Sebastian Mendez-Pineda, Hélène Blanché, Anne Boland, Jean-François Deleuze, Xiang-Yu Meng, Karine Groussard, Thierry Lebret, Julia Bonastre, Yves Allory, François Radvanyi, Simone Benhamou, Stefan Michiels

Cancer Res (2023) 83 (7_Supplement): 5224.

https://doi.org/10.1158/1538-7445.AM2023-5224

Published: 04 April 2023

View articletitled, Abstract 5224: Genome-wide interaction study of smoking and bladder cancer risk: results from the COBLAnCE cohort

Journal Articles

Abstract 4534: National Multidisciplinary Tumor Board improves diagnostic stratification and therapeutic management in Cancers of Unknown Primary: the French Experience

Cancer Res (2023) 83 (7_Supplement): 4534.

https://doi.org/10.1158/1538-7445.AM2023-4534

Published: 04 April 2023

View articletitled, Abstract 4534: National Multidisciplinary Tumor Board improves diagnostic stratification and therapeutic management in Cancers of Unknown Primary: the French Experience

Journal Articles

Abstract 66: BCG can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

Cancer Res (2021) 81 (13_Supplement): 66.

https://doi.org/10.1158/1538-7445.AM2021-66

Published: 01 July 2021

View articletitled, Abstract 66: BCG can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

Journal Articles

Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens

Myriam Lassalle, Claire Béraud, Hervé Lang, Véronique Lindner, Yves Allory, Eric Potiron, Thierry Massfelder, Philippe Lluel, Yolande Misseri

Cancer Res (2020) 80 (16_Supplement): 1668.

https://doi.org/10.1158/1538-7445.AM2020-1668

Published: 15 August 2020

View articletitled, Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens

Journal Articles

Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features

Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, María L. Suárez-Solís, Luis C. Fernández, Enrique Carrillo-de-Santa-Pau, Natalia del Pozo, Jaime Martínez de Villarreal, Clément Meiller, Yves Allory, Yuna Blum, Christine Pirker, Balazs Hegedus, Simon T. Barry, Amancio Carnero, Walter Berger, Didier Jean, Francisco X. Real

Cancer Res (2020) 80 (4): 843–856.

https://doi.org/10.1158/0008-5472.CAN-19-1633

Published: 14 February 2020

View articletitled, Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features

Includes: Supplementary data

Journal Articles

Abstract 1930: High specific characterization of patient-derived tumor xenograft models for accelerating drug development in muscle-invasive bladder cancers

Hervé Lang, Claire Beraud, Myriam Lassalle, Véronique Lindner, Michel Soulié, Xavier Gamé, Pascal Rischmann, Yves Allory, François Radvanyi, Isabelle Bernard-Pierrot, Philippe Lluel, Thierry Massfelder

Cancer Res (2019) 79 (13_Supplement): 1930.

https://doi.org/10.1158/1538-7445.AM2019-1930

Published: 01 July 2019

View articletitled, Abstract 1930: High specific characterization of patient-derived tumor xenograft models for accelerating drug development in muscle-invasive bladder cancers

Journal Articles

Abstract 1035: A comprehensive patient-derived tumor xenograft (PDX) collection representing the heterogeneity of kidney, prostate and bladder cancers

Hervé Lang, Claire Béraud, Myriam Lassalle, Isabelle Bernard-Pierrot, Véronique Lindner, Yves Allory, Michel Soulié, Xavier Gamé, Pascal Rischmann, Eric Potiron, François Radvanyi, Philippe Lluel, Thierry Massfelder

Cancer Res (2018) 78 (13_Supplement): 1035.

https://doi.org/10.1158/1538-7445.AM2018-1035

Published: 01 July 2018

View articletitled, Abstract 1035: A comprehensive patient-derived tumor xenograft (PDX) collection representing the heterogeneity of kidney, prostate and bladder cancers

Journal Articles

Abstract A29: Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas

Julien Calderaro, Julien Masliah-Planchon, Wilfrid Richer, Laetitia Planque, Pascale Maille, Alexandre de la Taille, Helene Boussion, Olivier Delattre, Yves Allory, Franck Bourdeaut

Cancer Res (2016) 76 (5_Supplement): A29.

https://doi.org/10.1158/1538-7445.PEDCA15-A29

Published: 04 April 2016

View articletitled, Abstract A29: Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas

Journal Articles

Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Guillaume Ploussard, Stéphane Terry, Pascale Maillé, Yves Allory, Nanor Sirab, Laurence Kheuang, Pascale Soyeux, Nathalie Nicolaiew, Estelle Coppolani, Bernard Paule, Laurent Salomon, Stéphane Culine, Ralph Buttyan, Francis Vacherot, Alexandre de la Taille

Cancer Res (2010) 70 (22): 9253–9264.

https://doi.org/10.1158/0008-5472.CAN-10-1447

Published: 14 November 2010

View articletitled, Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Includes: Supplementary data

Journal Articles

Abstract 5472: Class III beta-tubulin in castration resistant human prostate cancer

Stephane Terry, Guillaume Ploussard, Pascale Maillé, Yves Allory, Nathalie Nicolaiew, Pascale Soyeux, Laurence Kheuang, Stephane Culine, Ralph Buttyan, Alexandre de la Taille, Francis Vacherot

Cancer Res (2010) 70 (8_Supplement): 5472.

https://doi.org/10.1158/1538-7445.AM10-5472

Published: 15 April 2010

View articletitled, Abstract 5472: Class III beta-tubulin in castration resistant human prostate cancer

Journal Articles

Characterization of protocadherin-PC expression in prostate cancer

Stephane Terry, Yves Allory, Hugo Faucon, Asmaa El Atmani, Selcuk Keskin, Sandy Azoulay, Pascale Maille, Laurence Kheuang, Olivier Cussenot, Alexandre de la Taille, Ralph Buttyan, Francis Vacherot

Cancer Res (2007) 67 (9_Supplement): 4295.

Published: 01 May 2007

View articletitled, Characterization of protocadherin-PC expression in prostate cancer

Journal Articles

Characterization of PAR1 expression in human prostate cancer

Asmaa El Atmani, Yves Allory, Stephane Terry, Mihelaiti Chimingqi, Stephane Moutereau, Jean Claude Kouyoumdjian, Philippe Manivet, Olivier Cussenot, Sylvain Loric

Cancer Res (2007) 67 (9_Supplement): 2017.

Published: 01 May 2007

View articletitled, Characterization of PAR1 expression in human prostate cancer

Journal Articles

Protocadherin-PC activates LEF/TCF signaling and its mRNA is overexpressed in hormone-resistant human prostate cancer

Stephane Terry, Sixtina Gil-Diez De Medina, Luis Queires, Hugo Faucon, Alexandre De La Taille, Yang Xuezhen, Min-Wei Chen, Yves Allory, Clément C. Abbou, Ralph Buttyan, Dominique K. Chopin, Francis Vacherot

Cancer Res (2005) 65 (9_Supplement): 844–845.

Published: 01 May 2005

View articletitled, Protocadherin-PC activates LEF/TCF signaling and its mRNA is overexpressed in hormone-resistant human prostate cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 7642: Activated FAP+ cancer-associated fibroblasts in non-muscle invasive bladder cancer are associated with progression to muscle-invasive disease

Abstract 4627: Metastatic renal cell carcinoma with occult primary: Clinical and biological evidence for a new entity of cancers of unknown primary that beneficiates from tissue-tailored treatment

Abstract 4637: National multidisciplinary tumor board improves diagnostic stratification and therapeutic management in cancers of unknown primary

Abstract 5224: Genome-wide interaction study of smoking and bladder cancer risk: results from the COBLAnCE cohort

Abstract 4534: National Multidisciplinary Tumor Board improves diagnostic stratification and therapeutic management in Cancers of Unknown Primary: the French Experience

Abstract 66: BCG can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens

Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features

Abstract 1930: High specific characterization of patient-derived tumor xenograft models for accelerating drug development in muscle-invasive bladder cancers

Abstract 1035: A comprehensive patient-derived tumor xenograft (PDX) collection representing the heterogeneity of kidney, prostate and bladder cancers

Abstract A29: Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas

Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Abstract 5472: Class III beta-tubulin in castration resistant human prostate cancer

Characterization of protocadherin-PC expression in prostate cancer

Characterization of PAR1 expression in human prostate cancer

Protocadherin-PC activates LEF/TCF signaling and its mRNA is overexpressed in hormone-resistant human prostate cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only